XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.3
MARKETABLE SECURITIES
9 Months Ended
Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
MARKETABLE SECURITIES

NOTE 5 - MARKETABLE SECURITIES

 

As of December 31, 2024, all of the Company’s investment in marketable securities had contractual maturity of less than one year.

 

The table below sets forth a summary of the changes in the fair value of the Company’s marketable securities for the nine-month period ended September 30, 2025, and 2024:

 

   2025   2024 
  

Nine months ended

September 30,

 
   2025   2024 
   ($ in thousands) 
         
Balance at beginning of the period  $15,721    29,383 
Additions   11,749    14,444 
Maturity   (27,648)   (20,000)
Interest received   (109)   (217)
Changes in fair value during the period   287    974 
Balance at end of the period   -    24,584 

 

The Company elected the fair value option to measure and recognize its investments in debt securities in accordance with Accounting Standards Codification ASC 825, Financial Instruments as the Company managed and evaluated the performance on a fair value basis.

 

 

INSPIREMD, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS